Advanced Cell Technology Inc. , a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology, stock volume was low Oct. 20, with just 83,424 shares changing hands, a quarter of its average 30-day volume of 320,687 shares. announced the appointment of LeRoux Jooste to the newly created position of Senior Vice President of Business Development and Chief Commercial Officer.
http://ift.tt/1t7PO9l
http://ift.tt/1t7PO9l
No comments:
Post a Comment